FONGIT
The Start up Factory
CTI Start up
The Commission for Technology and Innovation (CTI) is mandated by the Swiss Confederation to support high tech projects and sustainable new business ventures by providing training, coaching and access to investors. This strategic mission fosters growth, creation of jobs and global competitiveness to assure Switzerland’s future economic wealth. CTI Start-up supports entrepreneurs with a tailored hands-on coaching process in four phases lasting 6 to 24 month’s. A dedicated coach is instrumental in bringing the start-up to the CTI Start-up Label, which represents quality, sustainability and credibility for investors, and favours successful market entry. The coaching support being free of charge all what start-ups need to invest is time and effort. CTI Start-up leverages the networks of its over 60 business coaches in all relevant areas for start-ups (e.g. strategy, operations, business, law, finance). CTI Start-up values its partnership with Fongit whose coaches are part of CTI Start-up expert’s network. Fongit acts as partner for CTI Start-up in the Geneva region.
Fongit Seed Invest
Fongit Seed Invest (FSI) is a seed investment fund that primarily invests in ventures having a potential market above CHF 100 million, and with projected revenue higher than CHF 5 million per year, within 5 years. FSI acts either as a lead investor or co-investors and has strong connections with venture capitalists, business angels, and institutional funds (PPP). FSI is known throughout the network of universities, Venture Capitalists, Business Angels and specialised organisations (private & public). Fongit is the major shareholder and primary partner and FSI’s funding members are: the CIA Pension Fund of the Geneva Canton (Caisse de Prévoyance CIA) and Rolex Pension Fund (Caisse de Pensions Paritaire Rolex) are other contributors.
BioXpress Therapeutics
Located in Geneva, Switzerland, BioXpress Therapeutics SA (BXT) is a premier provider of high-quality biosimilar monoclonal antibody (MAbs) for unmet need indications. As a class, MAbs are forecasted to grow at a CAGR approaching 10% over the next five years, driven largely by positive results in the clinic. Cancers and immune-related inflammatory diseases will continue to be leading markets for MAbs during the next five-years.BXT is focused on developing the highest quality product under strict European Medicines Agency (EMA) guidelines. We bring together the world’s top biologic development, manufacturing and regulatory experts dedicated to assuring the quality of our drugs. BXT believes all patients should have access to safe and high-quality biologic therapeutics at affordable costs.
Viroblock
Viroblock aims to launch a break through anti-viral face mask by mid 2012. Current face-masks (surgical, FFP2, N95) provide limited protection to wearers against respiratory viruses (H1N1,H5N1, SARS, RSV, etc) as they fail to filter out or kill these viruses. The new Viroblock mask uses a patented coating to kill all such viruses on pass through air thereby protecting the wearer and reducing infection.Targeted first at professionals who have a risk of viral infections (e.g., dentists, A&E staff, first responders). Viroblock technology has been shown to kill all enveloped viruses tested, including H1N1, H5N1, SARS, HIV and HSV. No resistance has been seen nor is expected as Viroblock technology targets a non-coded part of these viruses. Viroblock’s technology can be used in other products (e.g. nasal spray, vaginal gel).
Tegona
Tegona is a forward-thinking software house that is specialised in IT security and critical software development. Its customer’s base counts large corporations and governments based in Europe and in emerging countries.Its forte is in the information security field, particularly in identification and authentication and develops secure applications software for smartcard systems, NFC devices and the Internet of things. Tegona offers complete, modular and bespoke solutions, and leverages close cooperation with market's renowned stakeholders, mainly in ID, health and payment markets. Its partnership with local integrators and partners enable Tegona to tailor its solutions perfectly to its customers’ needs.
Dextens
Dextens develops, produces and commercializes measurement instruments for the beverage, semiconductor, steam power, pharmaceutical and chemical industries. Our instruments determine oxygen, ozone, carbon dioxide, hydrogen and nitrogen levels in both liquid and gaseous mediums and are ideal for high precision measurement in harsh conditions. The full development and optimization of products is carried out internally and the production is outsourced to Swiss manufacturers. Thus far, we have a set up a solid distribution network in Europe, the Americas, Asia and Australia, and looks at expanding and strengthening its presence worldwide. Our revenue streams come by replacing installed products from competitors and by entering into market segments with new applications.
Powersens
Powersens is a start up developing and selling smart electronic shoe-insoles for the medical market. The insoles placed inside the shoe, monitors and records foot plantar pressure and body movement throughout the day. They help users for interactive walking/sport rehabilitation and can diagnostic orthopaedic complications such as diabetic foot ulcers. This high potential medical device will improve lifetime and health conditions of millions of people.
Medicontur
Medicontur develops, manufactures and promotes intraocular implants which meet patients and surgeons' expectations. Twenty years of continuous growth, coupled with an exemplary proven safety record, has meant that distributors in many countries worldwide now rely on Medicontur's commitment to quality.Medicontur offers a full range of Aspheric Hydrophilic/ Aspheric Hydrophobic IOL’s for MICS and MINI incisions, also available with a Natural yellow filter as well as Toric IOL’s, CTR's and disposable injection kits.
SalsaDev
salsaDev SA is a software company specialized in advanced, intelligent technologies capable to understand complex, unstructured sources of text. Designed for the enterprise market, the software can automatically organize and find documents, saving considerable time and efforts for organizations and its employees.The main features of salsaDev software are designed specifically to ease the strain on information workers by providing Semantic Search, Automatic Categorization and Conceptually Related Content. Traditional systems use full text indexing and work with structured information such as tags, categories and metadata. These approaches, when faced with the unstructured raw data typically seen in enterprise scenarios, rapidly become inapplicable.
Augurix
Augurix product allows the screening, diagnosing and monitoring of Celiac Disease (intolerance to gluten), one of the most under-diagnosed medical conditions worldwide.Its proprietary diagnostic platform, Simtomax®Blood Drop, enables seamless and rapid screening at the point of care, from whole blood, serum, plasma in about 10 minutes. Using a small drop of blood, Simtomax® Blood Drop delivers lab-accurate results for: (i) Immunoglobulin-A (IgA), (ii) Immunoglobulin-G (IgG) and (iii) Total IgA level. Simtomax, CE compliant Augurix' first product-line received the 2010 Frost&Sullivan Product Differentiation Excellence Award in Point of Care Testing.Augurix is a family-driven business. Its family's personal experience of living with Celiac Disease is a constant reminder that drives its motivation.